Design, synthesis, and mechanistic evaluation of novel benzimidazole-hydrazone compounds as dual inhibitors of EGFR and HER2: Promising candidates for anticancer therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Design, synthesis, and mechanistic evaluation of novel benzimidazole-hydrazone compounds as dual inhibitors of EGFR and HER2: Promising candidates for anticancer therapy

Published:2024-08 Issue: Volume:1309 Page:138177
ISSN:0022-2860
Container-title:Journal of Molecular Structure
language:en
Short-container-title:Journal of Molecular Structure

Author:

Mirgany Tebyan O.,Rahman A.F.M. Motiur^ORCID,Alanazi Mohammed M.

Funder

King Saud University

Publisher

Elsevier BV

Reference53 articles.

1. Global cancer statistics 2022: the trends projection analysis;Chhikara;Chem. Biol. Lett.,2023

2. Cancer statistics for the year 2020: an overview;Ferlay;Int. J. cancer,2021

3. Design and synthesis of benzimidazole-chalcone derivatives as potential anticancer agents;Hsieh;Molecules,2019

4. The protein kinase complement of the human genome;Manning;Science,2002

5. Small-molecule inhibitors of the receptor tyrosine kinases: promising tools for targeted cancer therapies;Hojjat-Farsangi;Int. J. Mol. Sci.,2014

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of 1H-benzo[d]imidazole-(halogenated) Benzylidenebenzohydrazide Hybrids as Potential Multi-Kinase Inhibitors;Pharmaceuticals;2024-06-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP